Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01904903
Title Cardiac Safety Study in Patients With HER2+ Breast Cancer (SAFE-HEaRt)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington Hospital Center
Indications

Her2-receptor positive breast cancer

Therapies

Pertuzumab

Ado-trastuzumab emtansine

Trastuzumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington Cancer Institute at MedStar Washington Hospital Center Washington District of Columbia 20010 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20057 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field